This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dykstra's Deep-in-the-Money Call: Citigroup

Down doesn't necessarily mean out. That is a point I have tried to emphasize in my columns throughout the years.

No one exemplifies this better than Jon Lester. Lester is certainly not a household name, but his story is a great one. The 24-year-old lefty pitched the first no-hitter in the Bigs this season last night, topping the Kansas City Royals by a score of 7-0.

Lester, who pitches for the Boston Red Sox and won the final game of the 2007 World Series, survived large cell lymphoma in late 2006. It is now in remission. Lester is a winner and didn't let his difficult circumstances stop him from climbing to the top.

This is a great story that applies to sports, life and the markets.

Today I'm going with Citigroup (C - Get Report). The company is a heavy hitter and one that has gotten knocked around in the last few months.

Things have been so bad for the company, it is trading at its lowest levels in almost a decade. In fact, it hit its 52-week low of $17.99 in mid-March and is still trading well below its highest point ($55.53) in the last year. It closed at $22.99 on Monday and is off 58% in the last year.

Even with all its subprime problems, it's hard to believe we can grab shares of Citigroup at such a steal, but now is the time to get in this game.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BAC $15.31 -0.71%
C $51.00 -0.37%
DB $34.47 0.00%
JPM $59.55 0.02%
AAPL $123.25 -0.80%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs